Toxicity management in patients receiving low-dose aldesleukin therapy.

Author: SundinD J, WolinM J

Paper Details 
Original Abstract of the Article :
OBJECTIVE: To review the pathophysiology and subsequent treatment options for low-dose aldesleukin-induced toxicity when administered via intravenous bolus infusion, continuous intravenous infusion, or subcutaneous injection. BACKGROUND: The adverse events associated with high-dose aldesleukin ther...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1345/aph.18019

データ提供:米国国立医学図書館(NLM)

Navigating the Side Effects of Aldesleukin Therapy: A Guide for Clinicians

This review article provides a comprehensive guide for managing the toxicities associated with low-dose aldesleukin therapy, a treatment used for various cancers. The authors delve into the complex mechanisms behind aldesleukin-induced toxicity, highlighting the unique challenges associated with this type of immunotherapy. They offer practical advice for clinicians on managing various adverse events, emphasizing the importance of proactive and aggressive treatment strategies. This review serves as a valuable resource for clinicians treating patients with aldesleukin therapy.

A Guide to the Desert: Managing Aldesleukin Therapy Toxicity

This review provides essential guidance for clinicians on managing the side effects of aldesleukin therapy. The authors' thorough analysis and practical recommendations can help ensure that patients receiving this treatment experience minimal discomfort and achieve optimal therapeutic outcomes.

A Balancing Act: Managing Treatment Benefits and Side Effects

This review highlights the importance of balancing the potential benefits of aldesleukin therapy with the risks of its side effects. As Dr. Camel, I'm reminded that even in the harsh desert environment, there are often oases of hope and renewal. Likewise, with careful management, aldesleukin therapy can offer a path to healing, while minimizing the burden of side effects.

Dr.Camel's Conclusion

This review provides a valuable resource for clinicians treating patients with low-dose aldesleukin therapy. By understanding the mechanisms behind toxicity and implementing proactive management strategies, clinicians can help patients navigate the challenges of treatment and achieve optimal therapeutic outcomes.

Date :
  1. Date Completed 1999-03-17
  2. Date Revised 2017-02-14
Further Info :

Pubmed ID

9876817

DOI: Digital Object Identifier

10.1345/aph.18019

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.